Skip to main content
Caplight Logo









Melanos Care

Melanos Care

Private
KrakówHealthcare & Life Scienceshttps://melanoscare.com/

Last Round

Pre Seed

Feb 23, 2026

Total Funding Raised

$1.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Melanos Care is a biotechnology company that develops bio-identical human melanin and active ingredients for skin protection, anti-aging, and pigmentation management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Advanced Materials

Business Model

B2C

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

bioidentical melaniniPSC technologyinduced pluripotent stem cellsiPSCbiotech ingredientsclean beautyexosomesdermocosmeticsphotoprotectionactive ingredientsskincare innovationcinnamic acid derivativeshyperpigmentation treatmentbiotech startuplab-grown skincare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Melanos Care Comparables

Compare Melanos Care with similar companies based on industry and business-model similarity.

Melanos Care comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oxyco
79%
Vantage Specialty Chemicals
72%
Reju, Inc.
69%

Melanos Care Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 23, 2026

Key People

Founding team and executive leadership

Marcin Majka

Chief Executive Officer Co-Founder

Founding Team

Melanos Care Investors

Notable investors and investment history

Melanos Care investors
InvestorRounds
Hard2beatPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 169% MoM.

  • Feb 23, 2026

    $1.5M round led by Hard2beat

Melanos Care Filings

Explore SEC and related filing metadata, where available.

Melanos Care filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Melanos Care's valuation, stock price, and market status.

Is Melanos Care a public or private company?

Melanos Care is a private company.

What is the current stock price of Melanos Care?

Melanos Care is a private company with no public stock price. No recent secondary market data is available.

How much is Melanos Care worth (valuation)?

Valuation information for Melanos Care is not publicly available.

Can I buy Melanos Care stock?

Melanos Care shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Melanos Care's last funding round?

Melanos Care's most recent funding round was Pre Seed on February 23, 2026.

Who are the main investors in Melanos Care?

Key investors in Melanos Care include Hard2beat.

Will Melanos Care IPO soon?

No public IPO plans have been announced for Melanos Care.

How can I track Melanos Care secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Melanos Care's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKraków
Employee Range3
Year Founded2023
Last FundingFeb 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?